PD-1 expression and IL-2 loss of cytomegalovirus- specific T cells correlates with viremia and reversible functional anergy
- PMID: 18510628
- DOI: 10.1111/j.1600-6143.2008.02279.x
PD-1 expression and IL-2 loss of cytomegalovirus- specific T cells correlates with viremia and reversible functional anergy
Abstract
Cytomegalovirus (CMV) represents a major cause of infectious complications after transplantation. Recently, chronic infections with lymphocyte choriomeningitis virus (LCMV), HIV or HCV were shown to be associated with functionally exhausted T cells characterized by high expression of the programmed death (PD)-1 molecule and altered cytokine expression patterns. We therefore hypothesized that functional exhaustion of CMV-specific CD4 T cells may determine impaired CMV control in patients after renal transplantation. In viremic transplant recipients, a significantly higher proportion of CMV-specific CD4 T cells was PD-1 positive (median 40.9%, 17.0-88.7%) as compared to nonviremic transplant patients (8.8%, 0.8-80.5%), dialysis patients (8.8%, 0-36.7%) or controls (3.2%, 0.3-15.4%, p < 0.0001). In line with functional impairment, PD-1-positive T cells produced significantly less IFNgamma as compared to PD-1-negative T cells (p < 0.0001). Moreover, unlike controls or nonviremic patients, CMV-specific T cells from viremic patients showed a significant loss of IL-2 production (p < 0.0001). Interestingly, functional anergy of CMV-specific CD4 T cells was reversible in that antibody-mediated blockade of PD-1 signaling with its ligands PD-L1/-L2 led to an up to 10-fold increase in CMV-specific proliferation. In conclusion, expression of PD-1 defines a reversible defect of CMV-specific CD4 T cells that is associated with viremia, and blocking PD-1 signaling may provide a potential target for enhancing the function of exhausted T cells in chronic CMV infection.
Similar articles
-
PD-1 analysis on CD28(-) CD27(-) CD4 T cells allows stimulation-independent assessment of CMV viremic episodes in transplant recipients.Am J Transplant. 2013 Dec;13(12):3132-41. doi: 10.1111/ajt.12480. Epub 2013 Oct 22. Am J Transplant. 2013. PMID: 24148296
-
Blockade of programmed death receptor-1 signaling restores expression of mostly proinflammatory cytokines in anergic cytomegalovirus-specific T cells.Transpl Infect Dis. 2013 Feb;15(1):79-89. doi: 10.1111/tid.12025. Epub 2012 Nov 26. Transpl Infect Dis. 2013. PMID: 23176118
-
Increased programmed death-1 molecule expression in cytomegalovirus disease and acute graft-versus-host disease after allogeneic hematopoietic cell transplantation.Biol Blood Marrow Transplant. 2009 Jul;15(7):872-80. doi: 10.1016/j.bbmt.2009.03.022. Biol Blood Marrow Transplant. 2009. PMID: 19539220 Free PMC article.
-
Programmed death 1 expression on HIV-specific CD4+ T cells is driven by viral replication and associated with T cell dysfunction.J Immunol. 2007 Aug 1;179(3):1979-87. doi: 10.4049/jimmunol.179.3.1979. J Immunol. 2007. PMID: 17641065
-
Upregulation of PD-1 expression on circulating and intrahepatic hepatitis C virus-specific CD8+ T cells associated with reversible immune dysfunction.J Virol. 2007 Sep;81(17):9249-58. doi: 10.1128/JVI.00409-07. Epub 2007 Jun 13. J Virol. 2007. PMID: 17567698 Free PMC article.
Cited by
-
Human Herpesvirus and the Immune Checkpoint PD-1/PD-L1 Pathway: Disorders and Strategies for Survival.Microorganisms. 2021 Apr 8;9(4):778. doi: 10.3390/microorganisms9040778. Microorganisms. 2021. PMID: 33917804 Free PMC article. Review.
-
T-cell exhaustion: characteristics, causes and conversion.Immunology. 2010 Apr;129(4):474-81. doi: 10.1111/j.1365-2567.2010.03255.x. Epub 2010 Feb 23. Immunology. 2010. PMID: 20201977 Free PMC article. Review.
-
Potential Impact of Human Cytomegalovirus Infection on Immunity to Ovarian Tumours and Cancer Progression.Biomedicines. 2021 Mar 30;9(4):351. doi: 10.3390/biomedicines9040351. Biomedicines. 2021. PMID: 33808294 Free PMC article. Review.
-
Skewed T cell responses to Epstein-Barr virus in long-term asymptomatic kidney transplant recipients.PLoS One. 2019 Oct 22;14(10):e0224211. doi: 10.1371/journal.pone.0224211. eCollection 2019. PLoS One. 2019. PMID: 31639143 Free PMC article.
-
Reverse vaccinology: developing vaccines in the era of genomics.Immunity. 2010 Oct 29;33(4):530-41. doi: 10.1016/j.immuni.2010.09.017. Immunity. 2010. PMID: 21029963 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials